Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
mercredi, novembre 18
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Quantum BioPharma Ltd
QNTM
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$1.59
0.15
10.42%
À la clôture: Nov 17, 4:00 PM EST
$1.44
N/A
Pré-ouverture: 7:00 AM EST
Get Report
Aperçu
Actualités
Graphiques
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Comparer
Rapport sur les stocks
Résultats:
Les résultats Q3 2026 ont été publiés le jeu. nov. 12th, avant l'ouverture du marché
Quantum BioPharma Financials
Quantum BioPharma (QNTM) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Top Wall Street Forecasters Revamp Thermo Fisher Scientific Expectations Ahead Of Q3 Earnings
Thermo Fisher reports Q3 earnings Oct. 21, with analysts expecting $6.40 EPS and $11.93B revenue; analysts remain bullish, raising price targets.
Avi Kapoor
PRO
Quantum BioPharma Q4 EPS $(0.71) Beats $(0.93) Estimate
Quantum BioPharma (NASDAQ:QNTM) reported quarterly losses of $(0.71) per share which beat the analyst consensus estimate of $(0.93) by 23.66 percent. This is a 65.53 percent increase over losses of $(2.06) per share from
Benzinga Newsdesk
PRO
Quantum BioPharma Q3 EPS $(1.25) Misses $(0.08) Estimate
Quantum BioPharma (NASDAQ:QNTM) reported quarterly losses of $(1.25) per share which missed the analyst consensus estimate of $(0.08) by 1462.5 percent. This is a 71.4 percent increase over losses of $(4.37) per share
Benzinga Newsdesk
PRO
Quantum BioPharma Q2 EPS $(3.23) Compared With $(0.08) YoY
Quantum BioPharma (NASDAQ:QNTM) reported quarterly losses of $(3.23) per share which missed the analyst consensus estimate of $(0.07) by 4514.29 percent. This is a 3937.5 percent decrease over losses of $(0.08) per share
Benzinga Newsdesk
Earnings Scheduled For May 6, 2025
Benzinga Insights
Dow Edges Higher; US Weekly Jobless Claims Increase
Avi Kapoor